Artificial Intelligence (AI) opens new horizons in the understanding, diagnosis and treatment of leukaemia Published on 04/10/2023 During the 12th edition of their Open Days, experts from MD Anderson in Houston and other national and international specialists presented some of the latest developments in this field to the participants.
IDH inhibitors give very positive results in relapsed acute myeloblastic leukemia patients with the mutation Published on 08/10/2019 Acting on this therapy target would give favorable results in both monotherapy and in combination with other agents, thus improving life expectancy of patients with acute myeloblastic leukemia (AML)